Central nervous system stimulants and drugs that suppress appetite, 2. Antidepressant drugs 3. Lithium 4. Drugs of abuse, 5. Hypnotics and sedatives, 6. Antipsychotic Drugs, 7. Antiepileptic Drugs, 8. Opioid analgesics and narcotic antagonists, 9. Anti-inflammatory and antipyretic analgesics and drugs used in gout, 10. General anesthetics and therapeutic gases, 11. Local anesthetics, 12. Neuromuscular blocking agents and skeletal muscle relaxants, 13. Drugs that affect autonomic functions or the extrapyramidal system, 14. Dermatological drugs, topical agents and cosmetics, 15. Antihistamines (H1-receptor antagonists), 16. Drugs acting on the respiratory tract, 17. Positive inotropic drugs and drugs used in dysrhythmias, 18. Beta-adrenoceptor antagonists and antianginal drugs, 19. Drugs acting on the cerebral and peripheral circulations, 20. Antihypertensive Drugs, 21. Diuretics, 22. Metals, 23. Metal antagonists, 24. Antiseptic drugs and disinfectant, 25. Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines, 26. Miscellaneous antibacterial drugs, 27. Antifungal Drugs, 28. Antiprotozoal Drugs, 29. Antiviral drugs, 30. Antiretroviral drugs, 31. Drugs used in tuberculosis and leprosy, 32. Antihelminthic drugs, 33. Vaccines, 34. Blood, blood components, plasma and plasma products, 35. Formulations used in nutrition, 36. Drugs affecting blood coagulation, fibrinolysis, and hemostasis, 37. Gastrointestinal Drugs, 38. Drugs that act on the immune system: cytokines and monoclonal antibodies, 39. Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs, 40. Corticotrophins, corticosteroids, and prostaglandins, 41. Sex hormones and related compounds, including hormonal contraceptives, 42. Thyroid hormones, iodine, and antithyroid drugs, 43. Insulin, other hypoglycemic drugs, and glucagon, 44. Miscellaneous hormones, 45. Drugs that affect lipid metabolism, 46. Cytostatic Drugs, 47. Radiological contrast agents, 48. Drugs used in ocular treatment, 49. Treatments used in complementary and alternative medicine, 50. Miscellaneous drugs and materials, medical devices and techniques, 51. Medication errors
Contributors
Lise Aagaard, PhD, HD(O) (Chapter 1)
Institute of Public Health, Clinical Pharmacology, Faculty of Health Sciences, University of Southern Denmark, JB Winsløws Vej 19, 2. 5000 Odense C, Denmark. E-mail: laagaard@health.sdu.dk.
Jeffrey K. Aronson, MA, MBChB, DPhil, FRCP, FBPharmacolS, FFPM (Hon) (Chapters 6, 8, 24, 34, 37, 41, 45)
University Department of Primary Care Health Sciences, New Radcliffe House, Radcliffe Observatory Quarter, Woodstock Road, Oxford OX2 6GG, UK. E-mail: jeffrey.aronson@phc.ox.ac.uk.
Charlotte I.S. Barker, BMBCh (Chapter 29)
Paediatric Infectious Diseases Research Group, Division of Clinical Sciences, St George’s, University of London, Cranmer Terrace, London SW17 0RE, and Faculty of Medicine, Imperial College, London, UK. E-mail: cisbark4444@doctors.org.uk.
Corrado Blandizzi, MD, PhD (Chapter 36)
Division of Pharmacology & Chemotherapy, Department of Internal Medicine, University of Pisa, Via Roma 55, 56126 Pisa, Italy. E-mail: c.blandizzi@gmail.com.
Andrew Byrne, BA, MB BCh, BAO, MRCPsych, MMedSc (Chapter 5)
St George's Park, Morpeth, Northumberland, NE61 2NU, UK.
Santos Castañeda, MD, PhD (Chapter 40)
Department of Rheumatology, IIS-Princesa, Hospital Universitario de La Princesa, c/ Diego de León 62, 28006-Madrid, Spain. E-mail: scastas@gmail.com.
K. Chan, PhD, DSc, FSB, FCP, FRPS, FRSM (Chapter 48)
Faculty of Pharmacy, The University of Sydney and National Institute of Complementary Medicine, University of Western Sydney, Locked Bag 1797, Penrith NSW 2571, Australia. E-mail: kelvin.chan@sydney.edu.au.
John R. Charpie, MD, PhD (Chapter 17)
Department of Pediatrics and Communicable Diseases, University of Michigan Health System, 1500 E. Medical Center Drive, Ann Arbor, MI 48109, USA. E-mail: jcharpie@med.umich.edu.
Taylor A. Choi, PhD (Chapter 26)
Chemical Sciences Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA 94720. E-mail: tchoi@lbl.gov.
N.H. Choulis, MD, PhD (Chapters 14, 49)
University of Athens, PO Box 51173, 14510 Kifisia, Greece. E-mail: nicoly@otenet.gr.
Steve S. Chung, MD (Chapter 7)
Barrow Neurological Institute, St Joseph's Hospital and Medical Center, Phoenix, Arizona, USA. E-mail: steve.chung@dignityhealth.org.
Jamie J. Coleman, MBChB, MA (Med Ed), MD, MRCP(UK) (Chapter 20)
School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. E-mail: j.j.coleman@bham.ac.uk.
Joan Costa, MD (Chapter 39)
Clinical Pharmacology Department, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Ctra. de Canyet s/n, 08916 Badalona, Spain. E-mail: joan.costa.pages@gmail.com.
D. Cowan, MBChB, PhD, MRCP (Glasgow) (Chapter 16)
Department of Respiratory Medicine, Glasgow Royal Infirmary, 16 Alexander Parade, Glasgow, G31 2ER, UK. E-mail: douglas.cowan@otago.ac.nz.
Anthony R. Cox, PhD (Chapter 20)
School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. E-mail: a.r.cox@bham.ac.uk.
Stephen Curran, BSc, MBChB, MMedSc, MRCPsych, PhD (Chapter 5)
Fieldhead Hospital, South West Yorkshire Mental Health NHS Trust, Ouchthorpe Lane, Wakefield, WF1 3SP, UK. E-mail: s.curran@hud.ac.uk.
Rinkoo Dalan, MBBS, FRCP(Edin), FAMS (Endocrinology) (Chapter 43)
Department of Endocrinology, Tan Tock Seng Hospital, DUKE-NUS Graduate Medical School, National University of Singapore, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. E-mail: rinkoo_dalan@ttsh.com.sg.
S. Dittmann, MD, DScMed (Chapter 32)
19 Hatzenporter Weg, 12681 Berlin, Germany. E-mail: sd.internat.immun.consult@t-online.de.
Rif S. El-Mallakh, MD (Chapter 3)
Mood Disorders Research Program, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, MedCenter One, 501 E Broadway, Suite 340, Louisville, Kentucky 40202, USA. E-mail: rselma01@louisville.edu.
M. Farré, MD (Chapter 39)
Human Pharmacology and Neurosciences, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Parc de Salut Mar, Universitat Autònoma de Barcelona, Doctor Aiguader 88, 08003 Barcelona, Spain. E-mail: mfarre@imim.es.
E. Flockton, MBChB, FRCA, FFICM (Chapter 10)
Department of Critical Care, Royal Liverpool University Hospital, Prescot Street, Liverpool, L7 8XP, UK. E-mail: Elizabeth.Flockton@rlbuht.nhs.uk.
Swaran J.S. Flora, PhD, FNASc (Chapter 22)
Division of Pharmacology & Toxicology, Defence Research and Development Establishment, Jhansi Road, Gwalior 474002, India. E-mail: sjsflora@drde.drdo.in; sjsflora@gmail.com.
Joshua M. Friedland-Little, MD (Chapter 17)
Department of Pediatrics and Communicable Diseases, University of Michigan Health System, 1500 E. Medical Center Drive, Ann Arbor, MI 48109, USA. E-mail: jmfriedl@med.umich.edu.
Luís Gales, PhD (Chapter 41)
Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, and Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Rua do Campo Alegre 823, 4150-180 Porto, Portugal. E-mail: lgales@ibmc.up.pt.
Jason C. Gallagher (Chapter 25)
School of Pharmacy, Temple University, Philadelphia, PA 19140, USA. E-mail: jasoncg@temple.edu.
Yonglin Gao, MD (Chapter 3)
Mood Disorders Research Program, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, MedCenter One, 501 E Broadway, Suite 340, Louisville, Kentucky 40202, USA. E-mail: ylgao001@louisville.edu.
Tatsuya Gomi, MD, PhD (Chapter 46)
Department of Radiology, Ohashi Medical Center, Toho University, Japan. E-mail: gomi@oha.toho-u.ac.jp.
Wilson I. Gonsalves, MD (Chapter 35)
Division of Hematology, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. E-mail: Gonsalves.Wilson@mayo.edu.
Makoto Hasegawa, MD (Chapter 46)
Department of Radiology, Toho University Ohashi Medical Center, Japan. E-mail: ma12x-4c@din.or.jp.
Yuichi Hattori, MD, PhD (Chapter 44)
Department of Molecular and Medical Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. E-mail: yhattori@med.u-toyama.ac.jp.
M.S. Jawahar, MD (Chapter 30)
Department of Clinical Research, National Institute for Research in Tuberculosis, Mayor Sathiyamoorthy Salai, Chetput, Chennai 600 031, India. E-mail: shaheedjawahar@gmail.com.
Lokesh Kumar Jha, MD (Chapter 38)
Division of Gastroenterology and Hepatology, 983285 Nebraska Medical Center, Omaha, NE 68198-3285, USA. E-mail: lokesh.jha@unmc.edu.
Jesco Kompardt, MD, FANZCA (Chapter 11)
Anaesthetic Department, Joondalup Health Campus, Shenton Ave, Joondalup WA 6027, Australia. E-mail: jesco.kompardt@googlemail.com.
Worapant Kriengsoontornkij, MD (Chapter 23)
Division of Ambulatory Pediatrics, Department of Pediatrics, Thalassemia Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. E-mail: sikwr@yahoo.com.
R. Latini, MD (Chapter 18)
Department of Cardiovascular Research, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156 Milan, Italy. E-mail: roberto.latini@marionegri.it.
Melvin K.S. Leow, MBBS, MMed(Int Med), MSc, PhD, FAMS, FACE, FACP, FRCP (Edin) (Chapter 43)
Department of Endocrinology, Tan Tock Seng Hospital, Singapore. E-mail: mleowsj@massmed.org.
J.M. Lestner, MBChB, MRes, MRCPCH (Chapter 29)
Paediatric Infectious Diseases Research Group, Division of Clinical Sciences, St George’s, University of London, Cranmer Terrace, London SW17 0RE, UK, and Faculty of Medicine, Imperial College, London, UK. E-mail: jlestner@nhs.net.
M. Leuwer, MD (Chapters 10,...
